Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
VA

VANIStockVivani Medical Inc

NASDAQ NMS - GLOBAL MARKET · Healthcare · US

$1.14 last close 2026-11-20
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment VANI's does — no target price to set, unlike a price alert.

Sharia status
NOT DETERMINED
Our own screen rated every one of the seven published methodologies and none passed, while our secondary compliance provider rates it compliant — we will not publish either as a verdict
Assessed 2026-08-25
0 of 7 pass our own screen — all 7 agree here
HTR non-permissible income 11.88%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure3 of 5 timeframes bullish · 52.2% aligned
VWAPPrice holding above VWAP ($1.08)
VolumeRelative volume 5.8× the 20-day average
Momentum10-day rate of change +6.5%

Vivani Medical Inc (VANI) was screened and our screen declined to rate it, so we publish no verdict, per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts

Still fetching analyst coverage — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.

Momentum (10d)
+6.5%
rate of change
SMC grade
D · 39
52.2% aligned
11.88%
Non-permissible income — HTR, from filings (2022-12-31)
D · 39
SMC grade — 52.2% timeframe alignment
+6.5%
Rate of change (10d)

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $98.3M as of 2026-11-19.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail from an earlier screen2 of 3 computed, both pass

This Fail was decided by an earlier screen. The figures below are from the latest filing, which could not decide it on its own: non-permissible income not measured. The earlier verdict stands until a screen can decide it.

RatioValueThresholdResult
Interest-bearing debt 17.71% 30.00% Pass(12.3pp buffer)
Interest-bearing investments 14.84% 30.00% Pass(15.2pp buffer)
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified
Usmani Fail 4 of 5 computed, 2 pass, 2 fail
RatioValueThresholdResult
Interest-bearing debt 49.31% 33.00% Fail(16.3pp over)
Interest-bearing investments 41.32% 33.00% Fail(8.3pp over)
Non-liquid assets 58.68% at least 20.00% Pass(38.7pp above the floor)
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified
Net liquid assets per share $8.0M under mkt cap $98.3M Pass
MSCI Fail 2 of 4 computed, both fail
RatioValueThresholdResult
Interest-bearing debt 49.31% 33.33% Fail(16.0pp over)
Cash + interest-bearing securities 41.32% 33.33% Fail(8.0pp over)
Accounts receivable
receivables not reported
not available 33.33% Unverified
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified
FTSE Fail 2 of 4 computed, 1 passes, 1 fails
RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass(33.3pp buffer)
Cash + interest-bearing securities 41.32% 33.33% Fail(8.0pp over)
Accounts receivable
receivables not reported
not available 50.00% Unverified
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified
Dow Jones Islamic Market Fail from an earlier screen2 of 4 computed, both pass

This Fail was decided by an earlier screen. The figures below are from the latest filing, which could not decide it on its own: accounts receivable, non-permissible income not measured. The earlier verdict stands until a screen can decide it.

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 18.48% 33.00% Pass(14.5pp buffer)
Cash + interest-bearing securities 15.49% 33.00% Pass(17.5pp buffer)
Accounts receivable
receivables not reported
not available 33.00% Unverified
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified
S&P Shariah Fail from an earlier screen2 of 4 computed, both pass

This Fail was decided by an earlier screen. The figures below are from the latest filing, which could not decide it on its own: accounts receivable, non-permissible income not measured. The earlier verdict stands until a screen can decide it.

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 19.49% 33.00% Pass(13.5pp buffer)
Cash + interest-bearing securities 16.33% 49.00% Pass(32.7pp buffer)
Accounts receivable
receivables not reported
not available 49.00% Unverified
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified
MSCI M-Series Fail from an earlier screen2 of 4 computed, both pass

This Fail was decided by an earlier screen. The figures below are from the latest filing, which could not decide it on its own: accounts receivable, non-permissible income not measured. The earlier verdict stands until a screen can decide it.

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 19.49% 33.33% Pass(13.8pp buffer)
Cash + interest-bearing securities 16.33% 33.33% Pass(17.0pp buffer)
Accounts receivable
receivables not reported
not available 49.00% Unverified
Non-permissible income
revenue is $0 - ratio undefined
not available 5.00% Unverified

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

FTSE Shariah Global Equity Index Series (% of total assets)debt ratio 33.3pts
Usmani (% of total assets)nonliquid assets ratio · floor 38.7pts
Usmani (% of total assets)debt ratio 16.3pts
MSCI Islamic Index (% of total assets)debt ratio 16.0pts
Usmani (% of total assets)investments ratio 8.3pts

The numbers the ratios are built from

Read from VANI's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $0 2026-09-30 RevenueFromContractWithCustomerIncludingAssessedTax
Interest-bearing debtShort and long-term borrowings $0 2026-09-30 no debt tag reported in 3+ years (treated as $0)
Cash and interest-bearing securitiesCash, equivalents and marketable securities $14.6M 2026-09-30 CashAndCashEquivalentsAtCarryingValue
Total assetsBalance sheet total $35.3M 2026-09-30 Assets
Market capDenominator for AAOIFI $98.3M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $84.3M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $89.4M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-12, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-03-26, period ended 2026-09-30. Screened 2026-11-19.

  • Total assets$35.3M
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-12
  • Interest-bearing debt$0
    no debt tag reported in 3+ years (treated as $0) · balance sheet as of 2026-09-30 · no filing link for this figure
  • Cash and interest-bearing securities$14.6M
    CashAndCashEquivalentsAtCarryingValue · period ended 2026-09-30 · 10-Q filed 2026-11-12
  • Revenue$0
    RevenueFromContractWithCustomerIncludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-03-26
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30 · no filing link for this figure
  • Market cap$98.3M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-19 · not a filing figure, so no link

3 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for VANI. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for VANI has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

Shariah-compliant alternatives

Compliant companies in Biotechnology listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
VRTXVertex Pharmaceuticals, Inc. $121.1B —
REGNRegeneron Pharmaceuticals, Inc. $85.3B —
ARGXArgen X SE - ADR $64.3B —
ONCBeOne Medicines Ltd. American Depositary Shares $40.4B —
ALNYAlnylam Pharmaceuticals Inc $31.6B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold VANI

1 of the 265 funds whose filed holdings we currently hold own VANI shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns VANI.

You may already own it

Widely held U.S. index funds. If you own one, you own VANI through it. None of them is a Shariah fund; the last column is our look-through of each.

FundVANI in fundFund compliant by weight
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%

Sorted by VANI’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names VANI once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding VANI
InvestorFirmPositionWeightAs of
Israel Englander Millennium Management $0M 0.0% 2026-09-30
Ken Griffin Citadel Advisors $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

1.601.431.271.100.942025-11-212026-05-262026-11-20

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.99
S2
1.02
S1
1.06
PIVOT
1.09
R1
1.13
R2
1.16
R3
1.20

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
1.09 – 1.39
±12.31% from 1.24, made 2026-09-27 · resolves 2026-10-04
STRONG SELL
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

BUY
19 indicators
OscillatorsBUY
3 buy · 2 neutral · 2 sell
Moving averagesNEUTRAL
6 buy · 0 neutral · 6 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)54.10NEUTRAL
Stochastic %K (14)93.15SELL
CCI (20)77.67NEUTRAL
Williams %R (14)-6.85SELL
MACD (12,26,9)0.01BUY
ROC (10)6.54BUY
Momentum (10)0.07BUY
EMA (10)1.08BUY
SMA (10)1.07BUY
EMA (20)1.09BUY
SMA (20)1.09BUY
EMA (30)1.11BUY
SMA (30)1.10BUY
EMA (50)1.15SELL
SMA (50)1.16SELL
EMA (100)1.21SELL
SMA (100)1.26SELL
EMA (200)1.23SELL
SMA (200)1.23SELL

About Vivani Medical Inc

Healthcare · Biotechnology

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

vivani.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 44
⏰ 4H BULLISH 28
🕐 1H BULLISH 98
⏱ 15-Min BULLISH 130
⏲ 5-Min RANGING 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+6.5%
Rate of change (10d)
5.8×
Volume vs its 20-day average
-0.03
MACD (no fresh cross)
$1.13
Volume POC (today)
$1.12 – $1.14
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Still fetching insider filings — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-17 · Asset managers net 895049 (-19081)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.